AOC3 gene expression positively correlated with high WHO grade, recurrence, and worse survival in glioma subgroups (p = 0.0081, p = 0.0117, and p = 0.0216 respectively; Figure 1D). This evidence concerns the gene AOC3 and central nervous system cancer.